Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Zach, Susanne ^a   Felk, Sandra ^a   Gillardon, Frank ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; PROTEIN KINASE C ZETA; PROTEIN SERINE THREONINE KINASE; PROTEIN STE20; SERINE THREONINE KINASE 24; SERINE THREONINE KINASE 25; SERINE THREONINE KINASE 3; TAU PROTEIN; THOUSAND AND ONE AMINO ACID KINASE 3; UNCLASSIFIED DRUG; JIK PROTEIN, HUMAN; LRRK2 PROTEIN, HUMAN; NERVE PROTEIN; PROTEIN KINASE C;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NEUROMODULATION; NEUROPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MOUSE; MUTATION; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; TRANSGENIC MOUSE;

MUS MUSCULUS;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 78049288601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013191     Document Type: Article

References (31)

1. Abeliovich A, Flint BM (2006) Parkinsonism genes: culprits and clues. J Neurochem 99: 1062-1072.
2. Mata IF, Wedemeyer WJ, Farrer MJ, Taylor JP, Gallo KA (2006) LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci 29: 286-293.
3. Biskup S, West AB (2009) Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease. Biochim Biophys Acta 1792: 625-633.
4. Melrose H (2008) Update on the functional biology of Lrrk2. Future Neurol 3: 669-681.
5. Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O'Neill E, et al. (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 15: 223-232.
6. Ko HS, Bailey R, Smith WW, Liu Z, Shin JH, et al. (2009) CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc Natl Acad Sci U S A 106: 2897-2902.
7. Taymans JM, Cookson MR (2010) Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau. Bioessays 32: 227-235.
8. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, Ueffing M (2007) A novel tandem affinity purification strategy for the efficient isolation and characterization of native protein complexes. Proteomics 7: 4228-4234.
9. Johne C, Matenia D, Li XY, Timm T, Balusamy K, et al. (2008) Spred1 and TESK1-two new interaction partners of the kinase MARKK/TAO1 that link the microtubule and actin cytoskeleton. Mol Biol Cell 19: 1391-1403.
10. Strange K, Denton J, Nehrke K (2006) Ste20-type kinases: evolutionarily conserved regulators of ion transport and cell volume. Physiology (Bethesda) 21: 61-68.
11. Sun X, Yin J, Starovasnik MA, Fairbrother WJ, Dixit VM (2002) Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 277: 9505-9511.
12. Sacktor TC (2008) PKMzeta, LTP maintenance, and the dynamic molecular biology of memory storage. Prog Brain Res 169: 27-40.
13. Wang L, Xie C, Greggio E, Parisiadou L, Shim H, et al. (2008) The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucinerich repeat kinase 2. J Neurosci 28: 3384-3391.
14. Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, et al. (2007) LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 405: 307-317.
15. Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, et al. (2009) Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 29: 13971-13980.
16. Timm T, Li XY, Biernat J, Jiao J, Mandelkow E, et al. (2003) MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1. EMBO J 22: 5090-5101.
17. Li Y, Liu W, Oo TF, Wang L, Tang Y, et al. (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 12: 826-828.
18. Gillardon F (2009) Leucine-rich repeat kinase 2 phosphorylates brain tubulinbeta isoforms and modulates microtubule stability-a point of convergence in parkinsonian neurodegeneration? J Neurochem 110: 1514-1522.
19. Meylan E, Tschopp J (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30: 151-159.
20. Ho CC, Rideout HJ, Ribe E, Troy CM, Dauer WT (2009) The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fasassociated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci 29: 1011-1016.
21. Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, et al. (2008) Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 27: 2432-2443.
22. Gloeckner CJ, Schumacher A, Boldt K, Ueffing M (2009) The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J Neurochem 109: 959-968.
23. Kumar A, Greggio E, Beilina A, Kaganovich A, Chan D, et al. (2010) The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS One 5: e8730.
24. Dan I, Watanabe NM, Kusumi A (2001) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 11: 220-230.
25. Ling P, Lu TJ, Yuan CJ, Lai MD (2008) Biosignaling of mammalian Ste20- related kinases. Cell Signal 20: 1237-1247.
26. Lorber B, Howe ML, Benowitz LI, Irwin N (2009) Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways. Nat Neurosci 12: 1407-1414.
27. Chen CB, Ng JK, Choo PH, Wu W, Porter AG (2009) Mammalian sterile 20- like kinase 3 (MST3) mediates oxidative-stress-induced cell death by modulating JNK activation. Biosci Rep 29: 405-415.
28. Pombo CM, Bonventre JV, Molnar A, Kyriakis J, Force T (1996) Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway. EMBO J 15: 4537-4546.
29. Chen L, Haider K, Ponda M, Cariappa A, Rowitch D, et al. (2001) Protein kinase C-associated kinase (PKK), a novel membrane-associated, ankyrin repeatcontaining protein kinase. J Biol Chem 276: 21737-21744.
30. Pearson RB, Kemp BE (1991) Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. Methods Enzymol 200: 62-81.
31. Liu XF, Tari PK, Haas K (2009) PKM zeta restricts dendritic arbor growth by filopodial and branch stabilization within the intact and awake developing brain. J Neurosci 29: 12229-12235.